Mechanisms of BK virus infection of renal cells and therapeutic implications

Journal of Clinical Virology

Volumn 71, Issue , 2015, Pages 59-62

  Mbianda, Christiane ^a,b   El Meanawy, Ashraf ^a   Sorokin, Andrey ^a  

^a MEDICAL COLLEGE OF WISCONSIN   (United States)

^b Nephrology Physicians LLC   (United States)

Author keywords

BK virus; Caveolar dependent Endocytosis; Cellular receptor; Renal transplantation; Statins

Indexed keywords

CIDOFOVIR; IMMUNOGLOBULIN; IMMUNOSUPPRESSIVE AGENT; LEFLUNOMIDE; PRAVASTATIN; PROTEIN VP1; RITUXIMAB; STEROID; VIRUS DNA; ANTIVIRUS AGENT;

BK VIRUS INFECTION; CELL TRANSPORT; CLINICAL FEATURE; DISEASE ASSOCIATION; HUMAN; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY CELL; KIDNEY DISEASE; NONHUMAN; PRIORITY JOURNAL; REVIEW; VIRUS ENTRY; VIRUS PARTICLE; BK VIRUS; EPITHELIUM CELL; PHYSIOLOGY; VIROLOGY;

ANTIVIRAL AGENTS; BK VIRUS; EPITHELIAL CELLS; HUMANS; VIRUS INTERNALIZATION;

EID: 84941554328     PISSN: 13866532     EISSN: 18735967     Source Type: Journal    
DOI: 10.1016/j.jcv.2015.08.003     Document Type: Review

References (28)

1. Randhawa P., Ramos E. BK viral nephropathy: an overview. Transplant. Rev. 2007, 21:77-85.
2. Costa C., Cavallo R. Polyomavirus-associated nephropathy. World J. Transplant. 2012, 2(6):84-94.
3. Ferreira-Gonzalez A., Sidiqui R. BK Virus in the transplant patient. Clin. Microbiol. Newslett. 2007, 29(16):121-128.
4. Krihna A., Prasad N. BK virus nephropathy in renal transplantation. Ind. J. Transplant. 2011, 5(4):182-190.
5. Dall A., Hariharan S. BK virus nephritis after renal transplantation. Clin. J. Am. Soc. Nephrol. 2008, 3(Suppl. 2):S68-S75.
6. Bohl D.L., Brennan D.C. BK virus nephropathy and kidney transplantation. Clin. J. Am. Soc. Nephrol. 2007, 2(Suppl. 1):S36-S46.
7. Liptak P., Kemeny E., Ivanyi B. Primer: histopathology of polyomavirus-associated nephropathy in renal allografts. Nat. Clin. Pract. Nephrol. 2006, 2(11):631-636.
8. Low J., Humes H.D., Szczypka M., Imperiale M. BKV and SV40 infection of human kidney tubular epithelial cells in vitro. Virology 2004, 323(2):182-188.
9. Eash S., Querbes W., Atwood W.J. Infection of vero cells by BK virus is dependent on caveolae. J. Virol. 2004, 78(21):11583-11590.
10. Dugan A.S., Eash S., Atwood W.J. Update on BK virus entry and intracellular trafficking. Transpl. Infect. Dis. 2006, 8(2):62-67.
11. Moriyama T., Marquez J.P., Wakatsuki T., Sorokin A. Caveolar endocytosis is critical for BK virus infection of human renal proximal tubular epithelial cells. J. Virol. 2007, 81(16):8552-8562.
12. Drachenberg C.B., Papadimitriou J.C., Wali R., Cubitt C.L., Ramos E. BK polyoma virus allograft nephropathy: ultrastructural features from viral cell entry to lysis. Am. J. Transplant. 2003, 3(11):1383-1392.
13. Nichols B. Caveosomes and endocytosis of lipid rafts. J. Cell Sci. 2003, 116(Pt 23):4707-4714.
14. Moriyama T., Sorokin A. BK virus (BKV): infection, propagation, quantitation, purification, labeling, and analysis of cell entry. Curr. Protoc. Cell Biol. 2009, Chapter 26: unit.
15. Low J.A., Magnuson B., Tsai B., Imperiale M.J. Identification of gangliosides GD1b and GT1b as receptors for BK virus. J. Virol. 2006, 80(3):1361-1366.
16. Moriyama T., Sorokin A. Intracellular trafficking pathway of BK Virus in human renal proximal tubular epithelial cells. Virology 2008, 371(2):336-349.
17. Eash S., Atwood W.J. Involvement of cytoskeletal components in BK virus infectious entry. J. Virol. 2005, 79(18):11734-11741.
18. Dugan A.S., Eash S., Atwood W.J. An N-linked glycoprotein with alpha(2,3)-linked sialic acid is a receptor for BK virus. J. Virol. 2005, 79(22):14442-14445.
19. Dugan A.S., Gasparovic M.L., Tsomaia N., Mierke D.F., O'Hara B.A., Manley K., et al. Identification of amino acid residues in BK virus VP1 that are critical for viability and growth. J. Virol. 2007, 81(21):11798-11808.
20. Gee G.V., Dugan A.S., Tsomaia N., Mierke D.F., Atwood W.J. The role of sialic acid in human polyomavirus infections. Glycoconj. J. 2006, 23(1-2):19-26.
21. Elphick G.F., Querbes W., Jordan J.A., Gee G.V., Eash S., Manley K., et al. The human polyomavirus, JCV, uses serotonin receptors to infect cells. Science 2004, 306(5700):1380-1383.
22. Hirsch H.H., Brennan D.C., Drachenberg C.B., Ginevri F., Gordon J., Limaye A.P., et al. Polyomavirus-associated nephropathy in renal transplantation: interdisciplinary analyses and recommendations. Transplantation 2005, 79(10):1277-1286.
23. Dharnidharka V.R., Cherikh W.S., Neff R., Cheng Y., Abbott K.C. Retransplantation after BK virus nephropathy in prior kidney transplant: an OPTN database analysis. Am. J. Transplant. 2010, 10(5):1312-1315.
24. Trofe J., Gordon J., Roy-Chaudhury P., Koralnik I., Atwood W., Eash S., et al. Basic and clinical research in polyomavirus nephropathy. Exp. Clin. Transplant. 2004, 2(1):162-173.
25. Moriyama T., Sorokin A. Repression of BK virus infection of human renal proximal tubular epithelial cells by Pravastatin. Transplantation 2008, 85(9):1311-1317.
26. Garcia-Ruiz C., Morales A., Fernandez-Checa J.C. Statins and protein prenylation in cancer cell biology and therapy. Anticancer Agents Med. Chem. 2012, 12(4):303-315.
27. Moon H., Hill M.M., Roberts M.J., Gardiner R.A., Brown A.J. Statins: protectors or pretenders in prostate cancer?. Trends Endocrinol. Metab. 2014, 25(4):188-196.
28. O'Hara B.A., Rupasinghe C., Yatawara A., Gaidos G., Mierke D.F., Atwood W.J. Gallic acid-based small-molecule inhibitors of JC and BK polyomaviral infection. Virus Res. 2014, 189:280-285.